日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ACVR2A attenuation impacts lactate production and hyperglycolytic conditions attracting regulatory T cells in hepatocellular carcinoma

ACVR2A 减弱会影响乳酸生成和高糖酵解状态,从而吸引肝细胞癌中的调节性 T 细胞。

Koya Yasukawa,Shu Shimada,Yoshimitsu Akiyama,Tomohiko Taniai,Yosuke Igarashi,Shu Tsukihara,Yoshiaki Tanji,Kentaro Umemura,Atsushi Kamachi,Atsushi Nara,Masahiro Yamane,Keiichi Akahoshi,Akira Shimizu,Yuji Soejima,Minoru Tanabe,Shinji Tanaka

Loss of KDM6B epigenetically confers resistance to lipotoxicity in nonalcoholic fatty liver disease-related HCC

KDM6B 的表观遗传缺失使非酒精性脂肪肝相关 HCC 具有抗脂毒性作用

Megumi Hatano, Yoshimitsu Akiyama, Shu Shimada, Kohei Yagi, Keiichi Akahoshi, Michiko Itoh, Minoru Tanabe, Yoshihiro Ogawa, Shinji Tanaka

RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer

RRM1 通过吉西他滨耐药性介导组蛋白乙酰化,并促进胰腺癌的侵袭性和 ECM 重塑

Hiroaki Ono, Yoshiki Murase, Hironari Yamashita, Tomotaka Kato, Daisuke Asano, Yoshiya Ishikawa, Shuichi Watanabe, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Atsushi Kudo, Yoshimitsu Akiyama, Shinji Tanaka, Minoru Tanabe

Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer

SETD1A组蛋白甲基转移酶新靶点的鉴定及其在胰腺癌中的临床意义

Takeshi Ishii, Yoshimitsu Akiyama, Shu Shimada, Ayano Kabashima, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Kosuke Ogawa, Hiroaki Ono, Atsushi Kudo, Minoru Tanabe, Shinji Tanaka

Regulation of 4-HNE via SMARCA4 Is Associated with Worse Clinical Outcomes in Hepatocellular Carcinoma

通过 SMARCA4 调节 4-HNE 与肝细胞癌的较差临床结果相关

Shiori Watabe, Yukari Aruga, Ryoko Kato, Genji Kawade, Yuki Kubo, Anna Tatsuzawa, Iichiroh Onishi, Yuko Kinowaki, Sachiko Ishibashi, Masumi Ikeda, Yuki Fukawa, Keiichi Akahoshi, Minoru Tanabe, Morito Kurata, Kenichi Ohashi, Masanobu Kitagawa, Kouhei Yamamoto

Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma

SFXN1 的缺失可减轻脂毒性并预测非病毒性肝细胞癌的不良预后

Kohei Yagi, Shu Shimada, Yoshimitsu Akiyama, Megumi Hatano, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Shuichi Watanabe, Keiichi Akahoshi, Hiroaki Ono, Minoru Tanabe, Shinji Tanaka

Erg25 Controls Host-Cholesterol Uptake Mediated by Aus1p-Associated Sterol-Rich Membrane Domains in Candida glabrata

Erg25 控制光滑念珠菌中由 Aus1p 相关富含甾醇的膜结构域介导的宿主胆固醇摄取

Okamoto, Michiyo; Takahashi-Nakaguchi, Azusa; Tejima, Kengo; Sasamoto, Kaname; Yamaguchi, Masashi; Aoyama, Toshihiro; Nagi, Minoru; Tanabe, Kohichi; Miyazaki, Yoshitsugu; Nakayama, Hironobu; Sasakawa, Chihiro; Kajiwara, Susumu; Brown, Alistair J P; Teixeira, Miguel C; Chibana, Hiroji

cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer

cGAS-STING 信号促进免疫细胞克服胰腺癌中的成纤维细胞障碍

Ayano Kabashima, Yuki Matsuo, Saki Ito, Yoshimitsu Akiyama, Takeshi Ishii, Shu Shimada, Atsushi Masamune, Minoru Tanabe, Shinji Tanaka

Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mucinous neoplasm

导管内乳头状粘液肿瘤癌区中的 Atoh1 维持肠道表型

Nobuhiro Katsukura, Sho Watanabe, Tomoaki Shirasaki, Shuji Hibiya, Yoshihito Kano, Keiichi Akahoshi, Minoru Tanabe, Susumu Kirimura, Takumi Akashi, Masanobu Kitagawa, Ryuichi Okamoto, Mamoru Watanabe, Kiichiro Tsuchiya

Inhibitor library screening identifies ispinesib as a new potential chemotherapeutic agent for pancreatic cancers

抑制剂库筛选确定 ispinesib 是一种治疗胰腺癌的新型潜在化疗药物

Yoshiki Murase, Hiroaki Ono, Kosuke Ogawa, Risa Yoshioka, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Daisuke Ban, Atsushi Kudo, Shinji Tanaka, Minoru Tanabe